癲癇患者拉莫三嗪血藥濃度的測(cè)定及臨床分析
[Abstract]:Aim to establish a high performance liquid chromatography (HPLC) method for the determination of lamotriazine (Lamotrigine,LTG) in patients with epilepsy, and to explore the relationship between the concentration of lamotriazine and the therapeutic effect and dose. Methods HPLC (high performance liquid chromatographic,HPLC was used to establish and verify the method for the determination of lamotriazine in human plasma. Tinidazole was used as internal standard, chloroform was used as extraction solvent, acetonitrile-0.02mol/LKH2PO4 (volume ratio was 25:75) was used as mobile phase. The mobile phase was eluted on Symmetry-C18WATO54275 (250mm 脳 4.6 mm, 5 渭 m) column. The column temperature was room temperature and the flow rate was 1.0mL min-1,. The detection wavelength is 210 nm. According to the above chromatographic conditions, 60 patients were divided into three groups: low concentration (1 渭 g / mL4), effective concentration (1 ~ 8 渭 g / mL49) and high concentration (8 渭 g / mL7) according to the serum concentration of LTG. Results the results were analyzed by SPSS16.0 software. Results the calibration curve of lamotriazine was linear in the range of 1 ~ 8 渭 g / mL (r = 0.9998). The detection limit was 0.5 渭 g / mL, and the recovery was 66.6 渭 g / mL,. The inter-day precision was 6.93%. In 49 of the 60 patients, the serum LTG concentration was in the range of 1 ~ 8 渭 g / mL, and 43 of them took 50 mg / mL of LTG. When the plasma concentration was between 1 渭 g / mL and 8 渭 g / LTG, LTG had a good therapeutic effect on epilepsy, and there was a significant difference in the effective rate between comprehensive seizure and partial seizure (P0.05). Conclusion the established high performance liquid chromatography is simple, sensitive, economical and cheap. It is suitable for routine clinical LTG blood concentration monitoring and pharmacokinetic study. LTG is effective for many types of epilepsy, and the dosage of LTG is within the range of 50mg~200mg. The plasma concentration of 1 ~ 8 渭 g / mL,LTG in most of the patients was more effective than that of the control group (1 ~ 8 渭 g / mol) in the treatment of all-round seizure.
【學(xué)位授予單位】:寧夏醫(yī)科大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2014
【分類號(hào)】:R742.1
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 王穎慧;王麗;王云秀;吳曄;;拉莫三嗪血藥濃度與療效的關(guān)系[J];兒科藥學(xué)雜志;2010年02期
2 和凡;何艷玲;;拉莫三嗪藥代動(dòng)力學(xué)及兒科臨床應(yīng)用的進(jìn)展[J];兒科藥學(xué)雜志;2010年04期
3 歐陽冬生,陳小平,黃松林,余邦寧,譚志榮,周淦,王丹,周宏灝;拉莫三嗪片人體藥代動(dòng)力學(xué)和相對(duì)生物利用度[J];中國臨床藥理學(xué)雜志;2003年04期
4 宋志彬,廖衛(wèi)平,易詠紅,鄭宣,揚(yáng)春霞,趙綺華,蒲蜀湘;拉莫三嗪在有效血藥濃度時(shí)對(duì)腦電波的影響[J];廣州醫(yī)學(xué)院學(xué)報(bào);2003年04期
5 趙明明;孫亞欣;陳雨卉;朱旭;肇麗梅;;拉莫三嗪的藥代動(dòng)力學(xué)研究進(jìn)展[J];廣東藥學(xué)院學(xué)報(bào);2012年05期
6 胡永獅,吳平,湯秋華;抗癲癇藥拉莫三嗪的血藥濃度測(cè)定及動(dòng)物的藥代動(dòng)力學(xué)研究[J];華西藥學(xué)雜志;2001年01期
7 葉廣仁;宋志彬;鄭國俊;廖衛(wèi)平;易詠紅;;中國成年人拉莫三嗪藥代動(dòng)力學(xué)及丙戊酸對(duì)其影響[J];神經(jīng)疾病與精神衛(wèi)生;2007年03期
8 李琪;雷力力;張志國;汪鳳山;;HPLC法測(cè)定人血漿中的拉莫三嗪[J];黑龍江醫(yī)藥科學(xué);2011年06期
9 黃鉞;曹迪;李智平;;UGT1A4基因多態(tài)性對(duì)兒童拉莫三嗪藥動(dòng)學(xué)影響的研究進(jìn)展[J];中國臨床藥學(xué)雜志;2011年06期
10 顧婧;丁美萍;;拉莫三嗪在特殊人群中的應(yīng)用[J];中國臨床神經(jīng)科學(xué);2013年03期
本文編號(hào):2438644
本文鏈接:http://sikaile.net/yixuelunwen/shenjingyixue/2438644.html